Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic.

BACKGROUND The first pandemic season of A/H3N2 influenza virus (1968/1969) resulted in significant mortality in the United States, but it was the second pandemic season of A/H3N2 influenza virus (1969/1970) that caused the majority of deaths in England. We further explored the global pattern of mortality caused by the pandemic during this period. METHODS We estimated the influenza-related excess mortality in 6 countries (United States, Canada, England and Wales, France, Japan, and Australia) using national vital statistics by age for 1967-1978. Geographical and temporal pandemic patterns in mortality were compared with the genetic drift of the influenza viruses by analyzing hemagglutinin and neuraminidase sequences from GenBank. RESULTS In North America, the majority of influenza-related deaths in 1968/1969 and 1969/1970 occurred during the first pandemic season (United States, 70%; Canada, 54%). Conversely, in Europe and Asia, the pattern was reversed: 70% of deaths occurred during the second pandemic season. The second pandemic season coincided with a drift in the neuraminidase antigen. CONCLUSION We found a consistent pattern of mortality being delayed until the second pandemic season of A/H3N2 circulation in Europe and Asia. We hypothesize that this phenomenon may be explained by higher preexisting neuraminidase immunity (from the A/H2N2 era) in Europe and Asia than in North America, combined with a subsequent drift in the neuraminidase antigen during 1969/1970.

[1]  L. Simonsen,et al.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.

[2]  S. Lemon,et al.  Forum on Microbial Threats , 2020 .

[3]  H. Fukumi.  Summary report on Hong Kong influenza in Japan. , 1969, Bulletin of the World Health Organization.

[4]  R. Serfling,et al.  Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. , 1967, American journal of epidemiology.

[5]  Roden At.  National experience with Hong Kong influenza in the United Kingdom, 1968-69 , 1969 .

[6]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[7]  W. Dowdle,et al.  Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. , 1973, Bulletin of the World Health Organization.

[8]  R. Sharrar.  National influenza experience in the USA, 1968-69. , 1969, Bulletin of the World Health Organization.

[9]  J. R. Scotti,et al.  Available From , 1973 .

[10]  D. Roder,et al.  Mortality from influenza and allied infections in South Australia during 1968‐1981 , 1985, The Medical journal of Australia.

[11]  A. Monto,et al.  The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections. , 1971, American journal of epidemiology.

[12]  S B Thacker,et al.  Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962-1983. , 1988, Statistics in medicine.

[13]  G. Rocchi,et al.  Epidemiological evaluation of influenza in Italy. , 1974, Bulletin of the World Health Organization.

[14]  N. Cox,et al.  Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. , 2004, Virology.

[15]  J. Nguyen-Van-Tam,et al.  The epidemiology and clinical impact of pandemic influenza. , 2003, Vaccine.

[16]  G L Ada,et al.  Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.

[17]  N. Cox,et al.  Global epidemiology of influenza: past and present. , 2000, Annual review of medicine.

[18]  S. Lemon,et al.  Pandemic Influenza: Assessing Capabilities for Prevention and Response , 2005 .

[19]  W. Marine,et al.  Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man. , 1973, American journal of epidemiology.

[20]  A. Monto,et al.  The Tecumseh study of respiratory illness. II. Patterns of occurrence of infection with respiratory pathogens, 1965-1969. , 1971, American journal of epidemiology.

[21]  H. Fukumi.  Interpretation of influenza antibody patterns in man. Existence and significance of Hong Kong antibody in old people prior to the Hong Kong influenza epidemic. , 1969, Bulletin of the World Health Organization.

[22]  W. J. Housworth,et al.  The age distribution of excess mortality during A2 Hong Kong influenza epidemics compared with earlier A2 outbreaks. , 1971, American journal of epidemiology.

[23]  R. Sohier,et al.  Epidemiological data on Hong Kong influenza in France. , 1969, Bulletin of the World Health Organization.

[24]  Influenza in the world. , 2002, Releve epidemiologique hebdomadaire.

[25]  A. Monto,et al.  Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. , 1970, The Journal of infectious diseases.

[26]  J. W. Smith,et al.  Excess mortality associated with influenza in England and Wales. , 1977, International journal of epidemiology.

[27]  J. Mullooly,et al.  "A study of excess mortality during influenza epidemics in the United States, 1968-1976". , 1982, American journal of epidemiology.

[28]  W Ferreira,et al.  Origin and progress of the 1968-69 Hong Kong influenza epidemic. , 1969, Bulletin of the World Health Organization.

[29]  J. Kaiser.  Facing Down Pandemic Flu, the World's Defenses Are Weak , 2004, Science.

[30]  A. Monto,et al.  Effect of neuraminidase antibody on Hong Kong influenza. , 1973, Lancet.

[31]  D. Miller,et al.  Epidemiology of the Hong Kong/68 Variant of Influenza A2 in Britain , 1971, British medical journal.

[32]  C. Stuart-harris,et al.  Epidemiology of influenza in man. , 1979, British medical bulletin.

[33]  A. Langmuir,et al.  A critical evaluation of influenza surveillance. , 1969, Bulletin of the World Health Organization.

[34]  M. Cooney,et al.  Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. , 1979, JAMA.

[35]  I M Longini,et al.  Predicting the global spread of new infectious agents. , 1986, American journal of epidemiology.

[36]  R. Serfling.  Methods for current statistical analysis of excess pneumonia-influenza deaths. , 1963, Public health reports.

[37]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[38]  L. Simonsen,et al.  The virtues of antigenic sin: consequences of pandemic recycling on influenza-associated mortality , 2004 .

[39]  J Goodman,et al.  The value of a database in surveillance and vaccine selection , 2001 .

[40]  F. Assaad,et al.  Use of excess mortality from respiratory diseases in the study of influenza. , 1973, Bulletin of the World Health Organization.

[41]  C. Stuart-harris,et al.  Pandemic influenza: an unresolved problem in prevention. , 1970, The Journal of infectious diseases.

[42]  T. Francis,et al.  Interpretations of influenza antibody patterns of man. , 1969, Bulletin of the World Health Organization.

[43]  R. van Strik,et al.  Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. , 1993, International journal of epidemiology.

[44]  A. S. Beare.  Basic and applied influenza research , 1982 .

[45]  T. Reichert,et al.  A global pattern for influenza activity , 2001 .

[46]  E. D. Kilbourne,et al.  Perspectives on pandemics: a research agenda. , 1997, The Journal of infectious diseases.

[47]  A. Monto,et al.  The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. , 1975, American journal of epidemiology.